MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX •
Buy Open
Signal type
Buy
Status
Open
Open Price
$19.73
Stop Loss
$14.97
Performance
-4.82%
Days Open
5
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 10, 2026
Open Price $19.73
Stop Loss $14.97
Timespan Day
Company Profile
Name MoonLake Immunotherapeutics Class A Ordinary Shares
Ticker MLTX
Market Cap $2.96B
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $18.78
List Date Apr 6, 2022
Description
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
Website Open Company Website